SRI Logo
Spacer
    

Spacer
         
  SRI Logo

Contact SRI Biosciences

In Vitro Absorption and Metabolism Models

In vitro models to predict drug absorption and metabolism are valuable techniques for both screening new drug candidates, and later evaluations of potential drug-drug interactions. As a recognized leader in the field, SRI is an obvious choice to conduct these evaluations for clients. We offer the following services, among others:

  • Predict gastrointestinal absorption, using Caco2 cells.
    • Rapid screening in multi well plates, coupled to LC/MS detection detection, to quickly identify those compounds that can cross the GI tract into the blood stream.
    • Mechanism studies, evaluating flux rate and permeability constants from the apical to basolateral, and basolateral to apical directions.


  • Evaluate drug metabolism and drug interactions, using human and animal tissue models, as recommended by FDA. We have a bank of over 100 human liver specimens for these studies and ready access to fresh human hepatocytes.
    • Determine the metabolite profile of drug candidates using hepatocytes, liver and small intestine microsomes and S9, microsomes containing a single enzyme. These samples are rapidly analyzed by using LC-MS/MS and NMR.
    • Identify Phase I or Phase II enzymes responsible for metabolite formation.
    • Predict drug interactions due to inhibition or induction of drug metabolizing enzymes.
    • Identify pharmacogenetic effects on human drug metabolism


  • Study the transport properties of your drug, using bile canalicular membrane vesicles from animals and humans.

 


Contact SRI Biosciences

       Last Updated Jan 25, 2010

 

About Us  Vertical divider  R&D Divisions  Divider  Careers  Divider  Newsroom  Divider  Contact Us
©2010 SRI International 333 Ravenswood Avenue, Menlo Park, CA 94025-3493
SRI International is an independent, nonprofit corporation. Privacy policy